It confirms what the market already knows. Everyone is just waiting for the FDA to move on it.
The data will continue to get better on S2C. This is a shot across the FDA bow and they know it.
They have to react since they put a BS SOC out there already. NP holding a straight flush and FDA holding a pair. They both know what each other have now. What is the point of delaying the inevitable action? Besides letting Congress fill their stockings of CYdY stock before approval.